CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa

Hdl Handle:
http://hdl.handle.net/10144/336375
Title:
CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa
Authors:
Hoffmann, Christopher J; Schomaker, Michael; Fox, Matthew P; Mutevedzi, Portia; Giddy, Janet; Prozesky, Hans; Wood, Robin; Garone, Daniela B; Egger, Matthias; Boulle, Andrew
Journal:
Journal of Acquired Immune Deficiency Syndromes (1999)
Abstract:
In many resource-limited settings monitoring of combination antiretroviral therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or laboratory diagnostics. We examined whether the CD4 count slope over 6 months could provide additional prognostic information.
Affiliation:
Department of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. choffmann@jhmi.edu
Publisher:
Lippincott Williams & Wilkins
Issue Date:
1-May-2013
URI:
http://hdl.handle.net/10144/336375
DOI:
10.1097/QAI.0b013e318287c1fe
PubMed ID:
23344547
Language:
en
ISSN:
1944-7884
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorHoffmann, Christopher Jen_GB
dc.contributor.authorSchomaker, Michaelen_GB
dc.contributor.authorFox, Matthew Pen_GB
dc.contributor.authorMutevedzi, Portiaen_GB
dc.contributor.authorGiddy, Janeten_GB
dc.contributor.authorProzesky, Hansen_GB
dc.contributor.authorWood, Robinen_GB
dc.contributor.authorGarone, Daniela Ben_GB
dc.contributor.authorEgger, Matthiasen_GB
dc.contributor.authorBoulle, Andrewen_GB
dc.date.accessioned2014-11-30T16:10:08Z-
dc.date.available2014-11-30T16:10:08Z-
dc.date.issued2013-05-01-
dc.identifier.citationCD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa. 2013, 63 (1):34-41 J. Acquir. Immune Defic. Syndr.en_GB
dc.identifier.issn1944-7884-
dc.identifier.pmid23344547-
dc.identifier.doi10.1097/QAI.0b013e318287c1fe-
dc.identifier.urihttp://hdl.handle.net/10144/336375-
dc.description.abstractIn many resource-limited settings monitoring of combination antiretroviral therapy (cART) is based on the current CD4 count, with limited access to HIV RNA tests or laboratory diagnostics. We examined whether the CD4 count slope over 6 months could provide additional prognostic information.en_GB
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen_GB
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en_GB
dc.subjectHIV/AIDSen_GB
dc.subject.meshAdolescenten_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-HIV Agentsen_GB
dc.subject.meshAntiretroviral Therapy, Highly Activeen_GB
dc.subject.meshCD4 Lymphocyte Counten_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshPrognosisen_GB
dc.subject.meshProportional Hazards Modelsen_GB
dc.subject.meshRNA, Viralen_GB
dc.subject.meshSouth Africaen_GB
dc.subject.meshYoung Adulten_GB
dc.titleCD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africaen
dc.contributor.departmentDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. choffmann@jhmi.eduen_GB
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromes (1999)en_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.